When we subclassified the patients according to the hepatic histopathological classification, we then observed increased mRNA jejunal levels of TLR9 in SS as compared to those found in NL; increased levels were likewise present in NASH as compared to those in SS or NL (Figure 4D). Here, TLR9 is linked to metabolic dysfunction-associated steatohepatitis.